abstract |
The invention relates to peptides having a core sequence selected in the group comprising: SEQ ID N DEG 1: VDEAD, SEQ ID N DEG 2: LDEGD, SEQ ID N DEG 3: VDEGD, SEQ ID N DEG 4: VDESD, SEQ ID N DEG 5: LDEKD, SEQ ID N DEG 6: FDESD, SEQ ID N DEG 7: LDEAD, application as inhibitors of caspase-2 and/or -6 activity. |